$0.42
0.00% day before yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US2324373016
Symbol
CYAN

Cyanotech Corporation Stock price

$0.36
-0.06 14.56% 1M
-0.01 3.24% 6M
-0.01 1.86% YTD
-0.39 52.26% 1Y
-2.34 86.74% 3Y
-1.97 84.64% 5Y
-7.29 95.32% 10Y
-0.71 66.54% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
-0.06 14.76%
ISIN
US2324373016
Symbol
CYAN

Key metrics

Basic
Market capitalization
$3.0m
Enterprise Value
$10.4m
Net debt
$7.4m
Cash
$260.0k
Shares outstanding
7.2m
Valuation (TTM | estimate)
P/E
negative | -
P/S
0.2 | -
EV/Sales
0.6 | -
EV/FCF
negative
P/B
0.3
Financial Health
Equity Ratio
37.8%
Return on Equity
-36.1%
ROCE
-11.1%
ROIC
-7.0%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$18.3m | -
EBITDA
$-790.0k | -
EBIT
$-1.5m | -
Net Income
$-2.0m | -
Free Cash Flow
$-360.0k
Growth (TTM | estimate)
Revenue
- | -
EBITDA
- | -
EBIT
- | -
Net Income
- | -
Free Cash Flow
-
Margin (TTM | estimate)
Gross
29.5%
EBITDA
-4.3% | -
EBIT
-8.0%
Net
-10.9% | -
Free Cash Flow
-1.9%
More
EPS
$-0.3
FCF per Share
$0.0
Short interest
-
Employees
77
Rev per Employee
$310.0k
Show more

Is Cyanotech Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Financial data from Cyanotech Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
18 18
-
100%
- Direct Costs 13 13
-
71%
5.40 5.40
-
29%
- Selling and Administrative Expenses 6.50 6.50
-
35%
- Research and Development Expense 0.37 0.37
-
2%
-0.79 -0.79
-
-4%
- Depreciation and Amortization 0.67 0.67
-
4%
EBIT (Operating Income) EBIT -1.47 -1.47
-
-8%
Net Profit -2 -2
-
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Cyanotech Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cyanotech Corporation Stock News

Neutral
Business Wire
7 days ago
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q1FY26.
Neutral
Business Wire
about 2 months ago
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q4 & FYE 2025.
Neutral
Business Wire
6 months ago
KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q3FY25 and First Nine Months of Fiscal 2025.

Company Profile

Cyanotech Corp. engages in the development and commercialization of natural products derived from microalgae. Its products include BioAstin natural astaxanthin, a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health; and Spirulina Pacifica, a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.

Head office United States
CEO Matthew Custer
Employees 77
Founded 1983
Website www.cyanotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today